Hospital Sant Joan de Déu ( Site 4717)

Esplugues de Llobregat, Barcelona 8950

1 studies enrolling now · 1 studies all time

What they study most

Malignant Neoplasm

Studies at this site

• A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) — Recruiting now